Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2021;6(1):1857.DOI: 10.25107/2474-1663-v6-id1857

Case Series of Hepatocellular Carcinoma with the Atypical Contrast-Enhancement Ultrasound Enhancement Patterns and a Review of the Literature

Chen-Shan Wang, Bo Zhang and Jin-Tang Liao

Department of Medical Ultrasound, Wuhan First Hospital, China
Department of Medical Ultrasound, Central South University, China

*Correspondance to: Jin-Tang Liao 

 PDF  Full Text Case Series | Open Access

Abstract:

Hepatocellular Carcinoma (HCC) is a common cancer with high mortality worldwide, which typically manifests as "early entry and early exit" in CEUS, CECT and CEMRI. The case series in this study was characterized by the non-fading of the contrast agent. A total of 5 cases with atypical CEUS features confirmed by surgery and histopathological results were identified as HCC, and the
possible reasons for this phenomenon were analyzed. Therefore, the diagnosis of HCC with atypical contrast pattern requires a combination of multiple aspects.

Keywords:

HCC; CEUS; Atypical contrast pattern; Pathology; Tumor

Cite the Article:

Wang C-S, Zhang B, Liao J-T. Case Series of Hepatocellular Carcinoma with the Atypical Contrast-Enhancement Ultrasound Enhancement Patterns and a Review of the Literature. Clin Oncol. 2021;6:1857..

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

NLRP3 Inflammasome Enhances Tumor Growth
 Abstract  PDF  Full Text
CEA and CA19-9 Levels and KRAS Mutation Status as Biomarkers for Colorectal Cancer
 Abstract  PDF  Full Text
View More...